Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-small Cell Lung Cancer Metastatic × aumolertinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor 1

Interventions

tusamitamab ravtansine 2 pembrolizumab 1 dacomitinib 1 Ramucirumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡